/ BSX
/ Earnings
Earnings Recap: Boston Scientific, CME, and Johnson Controls Deliver Quarterly Beats
BSX, CME, and JCI have all reported strong earnings, surpassing expectations and demonstrating robust growth and resilience in their respective sectors.
February 04, 2026
BSX Shares Dip as Boston Scientific Unveils Biggest Deal in 20 Years
Boston Scientific stock slipped 3.6% in premarket trading after the company announced a $14.5 billion deal to buy Penumbra.
January 15, 2026
Boston Scientific Reports Strong Q3 2025 Results, Raises Full-Year Outlook
Boston Scientific reported Q3 2025 net sales of $5.07 billion and adjusted EPS of $0.75, topping expectations and supporting its upbeat full-year guidance.
October 22, 2025
Boston Scientific (BSX) Beats Q2 Expectations with Strong Growth
Boston Scientific's Q2 2025 results exceeded expectations, with net sales of $5.061 billion and adjusted EPS of $0.75.
July 23, 2025
Boston Scientific Corporation’s Q4 2024 Net Sales Surge by 22.4%, Exceeding Expectations
Boston Scientific Corporation reported robust financial results in Q4 2024, with net sales reaching $4.561 billion, a 22.4% increase from the previous year.
February 05, 2025
Back to 
